Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China

Detection of NDM-1-, CTX-M-15-, andqnrB4-Producing Enterobacter hormaechei Isolates in Brazil

(2014) Ana Paula D'Alincourt Carvalho-Assef et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China

(2014) Chuanming Zhang et al.   INFECTION GENETICS AND EVOLUTION

Dominance of CTX-M-Type Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from Patients with Community-Onset and Hospital-Onset Infection in China

(2014) Shu Xia et al.   PLoS One

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131

(2014) Mohamed H Al-Agamy et al.   Annals of Clinical Microbiology and Antimicrobials

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical Center

(2013) Kayoko Hayakawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolates

(2013) Xueqing Zhang et al.   BMC MICROBIOLOGY

Trends in Human Fecal Carriage of Extended-Spectrum  -Lactamases in the Community: Toward the Globalization of CTX-M

(2013) P.-L. Woerther et al.   CLINICAL MICROBIOLOGY REVIEWS

Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase

(2013) Á. Tóth et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Emergence of extended-spectrum  -lactamase (ESBL) CTX-M-8 in Germany

(2013) C. Eller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analysis of extended-spectrum- -lactamase-producing Escherichia coli isolates collected in the GERM-Vet monitoring programme

(2013) A.-K. Schink et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Characterization of CTX-M-type extended-spectrum beta-lactamase in clinical clones ofEscherichia coliin Southwest China

(2013) Wei-Dong Zhao et al.   JOURNAL OF BASIC MICROBIOLOGY

Detection of Resistance to Beta-Lactamase Inhibitors in Strains with CTX-M Beta-Lactamases: a Multicenter External Proficiency Study Using a Well-Defined Collection of Escherichia coli Strains

(2013) A. Ripoll et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Different Factors Associated with CTX-M-Producing ST131 and Non-ST131 Escherichia coli Clinical Isolates

(2013) Marie-Hélène Nicolas-Chanoine et al.   PLoS One

Effects of Ceftiofur and Chlortetracycline Treatment Strategies on Antimicrobial Susceptibility and on tet(A), tet(B), and blaCMY-2 Resistance Genes among E. coli Isolated from the Feces of Feedlot Cattle

(2013) Neena Kanwar et al.   PLoS One

The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China

(2013) Lei Zhang et al.   Annals of Clinical Microbiology and Antimicrobials

Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15

(2012) Sun Hee Park et al.   BMC INFECTIOUS DISEASES

Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producingEnterobacteriaceaebloodstream infections

(2012) Enrico Maria Trecarichi et al.   Future Microbiology

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence characterization of extended-spectrum β-lactamases amongEscherichia coliisolates collected in Zhengzhou

(2009) Zhijian Zhang et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS